University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer ...

Immunotherapy has changed the way physicians treat cancer patients. This approach to therapy targets the immune system to redirect cells toward the tumor. | Immunology ...

Gut bacteria are to blame for the failure of immune checkpoint therapy for ovarian cancer, new research reveals.

University of Virginia Cancer Center researchers have explained the failure of immune checkpoint therapy for ovarian cancer by discovering how gut bacteria interfere with the treatment.

In addition to sparing healthy tissue from damage, this cancer treatment platform is able to deliver orders of magnitude more therapy than the administered dose because the simple-to-manufacture ...

Recent research findings indicate that the vaginal microbiome, which are the community of bacteria ... cervical cancer screening (including Pap smears and HPV tests) and treatment.

Scientists have developed new light-sensitive chemicals that can radically improve the treatment of aggressive cancers with minimal side effects. In mouse tests, the new therapy completely eradicated ...

Each year, around 450,000 people die from OSCC, according to the International Agency for Research on Cancer. Scientists have long suspected that changes in bacteria in the mouth (the oral ...

Understanding the intricate interactions between oral bacteria and cancer cells is essential for advancing our approach to cancer treatment. Our study on Fusobacterium nucleatum provides a deeper ...

Immunotherapy has been emerging as a powerful strategy for cancer ... therapy of bacterial vaccine with conventional therapies may further achieve enhanced therapeutic benefits against cancers.